卵巢癌筛查的研究进展
2017-05-27陈仲波朱笕青
陈仲波+朱笕青
[摘要] 卵巢癌被认为最致命的癌症之一,但是早期卵巢癌的5年生存率却达90%以上。由于缺乏典型的症状和有效的筛选标准,只有25%左右的卵巢癌患者可以在早期(Ⅰ期)被发现,因此建立卵巢癌的筛查机制具有重大意义。目前卵巢癌筛查的目标人群主要是50岁以上的绝经妇女和遗传性卵巢癌家族的高危人群,筛查方法有血清CA125测定和阴道超声检查,筛查方案包括血清CA125测定、阴道超声检查和血清CA125测定联合阴道超声检查三种。随着对卵巢癌标志物研究的深入、影像学诊断方法的进步,卵巢癌的筛查取得了可喜的进展。
[关键词] 卵巢癌;高危人群;CA125;阴道超声检查;筛查
[中图分类号] ER737.31 [文献标识码] A [文章编号] 1673-9701(2016)35-0164-05
Research progress of ovarian cancer screening
CHEN Zhongbo ZHU Jianqing
Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China
[Abstract] Ovarian cancer is thought to be one of the most lethal cancers, but the 5 year survival rate of early ovarian cancer is over 90%. Due to the lack of typical symptoms and effective screening criteria, only about 25% of patients with ovarian cancer can be found in the early stage(Ⅰ stage), so the establishment of ovarian cancer screening system is of great significance. At present, the target population of ovarian cancer screening is mainly menopausal women over 50 years of age and high-risk population of hereditary ovarian cancer families. Screening methods are serum CA125 and transvaginal ultrasound examination. The screening program include the determination of serum CA125, transvaginal ultrasound and serum CA125 combined with transvaginal ultrasound examination. With the progress of the research of ovarian cancer markers and imaging diagnosis methods, ovarian cancer screening has made gratifying progress.
[Key words] Ovarian carcer; High risk population; CA125; Transvaginal ultrasound; Screening
卵巢癌在女性生殖器恶性肿瘤中的发生率占第3位,但其死亡率却居第1位[1]。由于卵巢解剖位置深居盆腔,卵巢癌的早期症状常很不明显,初期症状包括腹痛、腹胀、胃肠道不适等,因为这些症状更常见于其他疾病,患者往往会被误诊或延误诊断。待临床诊断确定时,约70%已属晚期,大多肿块已固定,出现腹水或远处转移等晚期症状,延误了治疗时机。近年來,虽然外科手术技术的改进可以做到最大限度的肿瘤细胞减灭术,同时也提出了不少新的化疗方案,但晚期卵巢癌的5年生存率仍徘徊在20%~30%左右[2],而早期卵巢癌患者,超过90%可以通过常规的手术和化疗获得治愈[3]。由于缺乏典型的症状和有效的筛选标准,只有25%的卵巢癌患者可以早期发现[4]。……
